Page last updated: 2024-09-03

dehydroevodiamine and Cognition Disorders

dehydroevodiamine has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SH; Jeong, SJ; Kim, HS; Kim, SS; Lee, SH; Lee, YJ; Park, CH; Suh, YH	1

Other Studies

1 other study(ies) available for dehydroevodiamine and Cognition Disorders

Article	Year
Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance. Journal of neurochemistry, 2000, Volume: 74, Issue:1 Topics: Alkaloids; Amnesia; Animals; Avoidance Learning; Cell Death; Cerebral Infarction; Cholinesterase Inhibitors; Cognition Disorders; Entorhinal Cortex; Hippocampus; Learning; Maze Learning; Memory; Muscarinic Antagonists; Neurons; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine	2000

Article

Year

Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance.

Journal of neurochemistry, 2000, Volume: 74, Issue:1

Topics: Alkaloids; Amnesia; Animals; Avoidance Learning; Cell Death; Cerebral Infarction; Cholinesterase Inhibitors; Cognition Disorders; Entorhinal Cortex; Hippocampus; Learning; Maze Learning; Memory; Muscarinic Antagonists; Neurons; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine

2000